"ST. LOUIS HEART AND VASCULAR State-Of-The-Art St. Louis Heart and Vascular, P.C. offers state-of-the-art cardiology care through our nationally renowned physicians and professional staff at multiple office locations throughout the St. Louis area. Unlike other practices that refer you out to clinics or hospitals for ultrasounds and CT scans, SLHV Cardiology offers the full gamut of both interventional and non-interventional cardiac services. In fact, SLHV Cardiology is the only private practice in St. Louis with an in-office PET scanner. Some of the services and state-of-the-art technologies they offer include both vascular and cardiac ultrasounds, coronary CAT scans, a catheterization lab, vein ablation, and echocardiograms."

During the past decade, St Louis Heart and Vascular conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 16 clinical trials were completed, i.e. on average, 45.7% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 9 clinical trials were completed. i.e. 64.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St Louis Heart and Vascular" #1 sponsor was "Bayer" with 6 trials, followed by "Biotronik, Inc." with 4 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored and "Boston Scientific Corporation" with 2 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St Louis Heart and Vascular" #1 collaborator was "Duke Clinical Research Institute" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Medtronic" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "St Louis Heart and Vascular" are "Heart Failure" (21 trials), "Atrial Fibrillation" (4 trials), "Coronary Artery Disease" (2 trials), "Heart Failure With Preserved Ejection Fraction" (2 trials) and "Myocardial Infarction" (2 trials). Many other conditions were trialed in "St Louis Heart and Vascular" in a lesser frequency.

Most popular intervention types in "St Louis Heart and Vascular" are "Drug" (21 trials), "Device" (17 trials), "Other" (6 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Apixaban" (3 trials), "Empagliflozin" (3 trials), "Neladenoson bialanate (BAY1067197)" (2 trials) and "ASA 100 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "St Louis Heart and Vascular" are 44 trials for "All" genders.

Currently, there are NaN active trials in "St Louis Heart and Vascular". undefined are not yet recruiting, 11 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in St Louis Heart and Vascular, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in St Louis Heart and Vascular, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 11 trials that are defined as “Not Applicable".